Tivic Health Systems Debt to Equity Ratio 1970-1969 | TIVC

Current and historical debt to equity ratio values for Tivic Health Systems (TIVC) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Tivic Health Systems debt/equity for the three months ending December 31, 1969 was 0.38.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
Tivic Health Systems Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.003B $0.001B
Tivic Health Systems Inc. is a commercial-phase healthtech company advancing bioelectronic medicine to deliver non-invasive solutions which treat disease, increase wellness and improve lives. Its first product includes ClearUP(R). Tivic Health Systems Inc. is based in MENLO PARK, Calif.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $42.890B 42.79
Tempus AI (TEM) United States $12.625B 0.00
10x Genomics (TXG) United States $9.470B 0.00
Hinge Health (HNGE) United States $7.563B 72.66
Hims & Hers Health (HIMS) United States $6.533B 0.00
Doximity (DOCS) United States $4.624B 28.50
Heartflow (HTFL) United States $4.200B 0.00
IRhythm Holdings (IRTC) United States $3.686B 243.09
Privia Health (PRVA) United States $2.602B 97.00
Clover Health Investments (CLOV) United States $2.422B 0.00
Inspire Medical Systems (INSP) United States $2.103B 32.05
Butterfly Network (BFLY) United States $1.933B 0.00
Schrodinger (SDGR) United States $1.767B 0.00
Omnicell (OMCL) United States $1.475B 21.06
Azenta (AZTA) United States $1.455B 79.07
Enovis (ENOV) United States $1.076B 5.57
Talkspace (TALK) United States $0.879B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.669B 0.00
Phreesia (PHR) United States $0.636B 34.13
Veradigm (MDRX) United States $0.597B 0.00
Fulgent Genetics (FLGT) United States $0.595B 0.00
Claritev (CTEV) United States $0.569B 0.00
Evolent Health (EVH) United States $0.423B 0.00
Carlsmed (CARL) United States $0.418B 0.00
Senseonics Holdings (SENS) United States $0.379B 0.00
CapsoVision (CV) United States $0.300B 0.00
Standard BioTools (LAB) United States $0.278B 0.00
American Well (AMWL) United States $0.221B 0.00
KORU Medical Systems (KRMD) United States $0.147B 0.00
Health Catalyst (HCAT) United States $0.130B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.117B 0.00
CareCloud (CCLD) United States $0.089B 6.53
Pulmonx (LUNG) United States $0.084B 0.00
Zepp Health (ZEPP) Netherlands $0.063B 0.00
Nyxoah SA (NYXH) Belgium $0.060B 0.00
Outset Medical (OM) United States $0.059B 0.00
P3 Health Partners (PIII) United States $0.055B 0.00
EUDA Health Holdings (EUDA) Singapore $0.050B 0.00
Precipio (PRPO) United States $0.048B 0.00
MDxHealth SA (MDXH) Belgium $0.034B 0.00
111 (YI) China $0.030B 0.00
Evaxion - (EVAX) Denmark $0.025B 0.00
HeartBeam (BEAT) United States $0.023B 0.00
Predictive Oncology (POAI) United States $0.020B 0.00
DataMeds AI (MEDS) United States $0.019B 0.00
HeartSciences (HSCS) United States $0.018B 0.00
Healthcare Triangle (HCTI) United States $0.010B 0.00
Lunai Bioworks (LNAI) United States $0.010B 0.00
Bullfrog AI Holdings (BFRG) United States $0.008B 0.00
ITonic Holdings (ITOC) China $0.005B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.001B 0.00
PROFUSA (PFSA) United States $0.001B 0.00
Zhongchao (ZCMD) China $0.001B 0.00
TruBridge (TBRG) United States $0.000B 0.00